Qiagen, Paradigm Genetics, Ciphergen, Lexicon Genetics, Orchid BioSciences | GenomeWeb

Qiagen Posts Strong Rise in Q2 Revenue As Income Narrows

Qiagen this week reported a 14-percent year-over-year increase in second quarter revenues, and decreased net income.

Revenue for the three-month period ended June 30 increased to $98.6 million from $86.3 million one year ago.

R&D expenses in the quarter increased to $9.3 million from $7.6 million year over year. As a result, net income fell to $8.8 million, or $.10 per share, from $11.1 million, or $.08 per share, in the second quarter of 2003.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.